327 related articles for article (PubMed ID: 34484175)
21. Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas.
Dawes JC; Uren AG
Front Immunol; 2021; 12():670280. PubMed ID: 34484175
[TBL] [Abstract][Full Text] [Related]
22. Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.
Tschida BR; Largaespada DA; Keng VW
Semin Cell Dev Biol; 2014 Mar; 27():86-95. PubMed ID: 24468652
[TBL] [Abstract][Full Text] [Related]
23. Advances in functional genetic screening with transposons and CRISPR/Cas9 to illuminate cancer biology.
O'Donnell KA
Curr Opin Genet Dev; 2018 Apr; 49():85-94. PubMed ID: 29587177
[TBL] [Abstract][Full Text] [Related]
24. PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas.
Noorani I; de la Rosa J; Choi YH; Strong A; Ponstingl H; Vijayabaskar MS; Lee J; Lee E; Richard-Londt A; Friedrich M; Furlanetto F; Fuente R; Banerjee R; Yang F; Law F; Watts C; Rad R; Vassiliou G; Kim JK; Santarius T; Brandner S; Bradley A
Genome Biol; 2020 Jul; 21(1):181. PubMed ID: 32727536
[TBL] [Abstract][Full Text] [Related]
25. Identifying transposon insertions and their effects from RNA-sequencing data.
de Ruiter JR; Kas SM; Schut E; Adams DJ; Koudijs MJ; Wessels LFA; Jonkers J
Nucleic Acids Res; 2017 Jul; 45(12):7064-7077. PubMed ID: 28575524
[TBL] [Abstract][Full Text] [Related]
26. Validation-Based Insertional Mutagenesis (VBIM), A Powerful Forward Genetic Screening Strategy.
De S; Tamagno I; Stark GR; Jackson MW
Curr Protoc; 2022 Mar; 2(3):e394. PubMed ID: 35316583
[TBL] [Abstract][Full Text] [Related]
27. Mouse Models of Germinal Center Derived B-Cell Lymphomas.
Meyer SN; Koul S; Pasqualucci L
Front Immunol; 2021; 12():710711. PubMed ID: 34456919
[TBL] [Abstract][Full Text] [Related]
28. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
Front Immunol; 2021; 12():683597. PubMed ID: 34335584
[TBL] [Abstract][Full Text] [Related]
29. Building the Next Generation of Humanized Hemato-Lymphoid System Mice.
Martinov T; McKenna KM; Tan WH; Collins EJ; Kehret AR; Linton JD; Olsen TM; Shobaki N; Rongvaux A
Front Immunol; 2021; 12():643852. PubMed ID: 33692812
[TBL] [Abstract][Full Text] [Related]
30. TALEN outperforms Cas9 in editing heterochromatin target sites.
Jain S; Shukla S; Yang C; Zhang M; Fatma Z; Lingamaneni M; Abesteh S; Lane ST; Xiong X; Wang Y; Schroeder CM; Selvin PR; Zhao H
Nat Commun; 2021 Jan; 12(1):606. PubMed ID: 33504770
[TBL] [Abstract][Full Text] [Related]
31. An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.
Flümann R; Rehkämper T; Nieper P; Pfeiffer P; Holzem A; Klein S; Bhatia S; Kochanek M; Kisis I; Pelzer BW; Ahlert H; Hauer J; da Palma Guerreiro A; Ryan JA; Reimann M; Riabinska A; Wiederstein J; Krüger M; Deckert M; Altmüller J; Klatt AR; Frenzel LP; Pasqualucci L; Béguelin W; Melnick AM; Sander S; Montesinos-Rongen M; Brunn A; Lohneis P; Büttner R; Kashkar H; Borkhardt A; Letai A; Persigehl T; Peifer M; Schmitt CA; Reinhardt HC; Knittel G
Blood Cancer Discov; 2021 Jan; 2(1):70-91. PubMed ID: 33447829
[TBL] [Abstract][Full Text] [Related]
32. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
[TBL] [Abstract][Full Text] [Related]
33. Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion.
Nahmad AD; Raviv Y; Horovitz-Fried M; Sofer I; Akriv T; Nataf D; Dotan I; Carmi Y; Burstein D; Wine Y; Benhar I; Barzel A
Nat Commun; 2020 Nov; 11(1):5851. PubMed ID: 33203857
[TBL] [Abstract][Full Text] [Related]
34. Single-cell mutation analysis of clonal evolution in myeloid malignancies.
Miles LA; Bowman RL; Merlinsky TR; Csete IS; Ooi AT; Durruthy-Durruthy R; Bowman M; Famulare C; Patel MA; Mendez P; Ainali C; Demaree B; Delley CL; Abate AR; Manivannan M; Sahu S; Goldberg AD; Bolton KL; Zehir A; Rampal R; Carroll MP; Meyer SE; Viny AD; Levine RL
Nature; 2020 Nov; 587(7834):477-482. PubMed ID: 33116311
[TBL] [Abstract][Full Text] [Related]
35. Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.
Duployez N; Jamrog LA; Fregona V; Hamelle C; Fenwarth L; Lejeune S; Helevaut N; Geffroy S; Caillault A; Marceau-Renaut A; Poulain S; Roche-Lestienne C; Largeaud L; Prade N; Dufrechou S; Hébrard S; Berthon C; Nelken B; Fernandes J; Villenet C; Figeac M; Gerby B; Delabesse E; Preudhomme C; Broccardo C
Blood; 2021 Mar; 137(10):1424-1428. PubMed ID: 33036026
[No Abstract] [Full Text] [Related]
36. Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery.
Lundin A; Porritt MJ; Jaiswal H; Seeliger F; Johansson C; Bidar AW; Badertscher L; Wimberger S; Davies EJ; Hardaker E; Martins CP; James E; Admyre T; Taheri-Ghahfarokhi A; Bradley J; Schantz A; Alaeimahabadi B; Clausen M; Xu X; Mayr LM; Nitsch R; Bohlooly-Y M; Barry ST; Maresca M
Nat Commun; 2020 Sep; 11(1):4903. PubMed ID: 32994412
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
